 Amgen announced a 28.3 billion plan to acquire Horizon Therapeutics on Monday, leading HZNP stock to soar higher. The post Amgen To Buy Rare Diseases Drugmaker Horizon Therapeutics In 28.3 Billion Deal appeared first on Investors Business Daily. 